Use the search parameters below to filter talks:

2010 - TTS International Congress (Vancouver)

Options and Outcomes in the Sensitized Kidney Recipient
16 August 2010  /  15:30 - 16:59
Terminal Complement Inhibition Decreases Early Acute Humoral Rejection in Sensitized Renal Transplant Recipients.
Presenter: Mark Stegall, United States
Report from an 80 Transplant Center Multi-regional Kidney Paired Donation Program
Presenter: Michael Rees, United States
Outcomes of Patients Desensitized For a Positive Crossmatch Compared To Patients Who Are Not Offered This Option
Presenter: Bonnie Lonze, United States

Molecular Mechanisms of Delayed Kidney Graft Function
16 August 2010  /  15:30 - 16:59
Association between ICAM-1 and VCAM-1 gene polymorphisms and graft function in early period after kidney transplantation.
Presenter: Leszek Domański, Poland
High-mobility group box1 (HMGB1) contributes to kidney ischemia reperfusion injury through TLR4 signaling
Presenter: Jin Ma,
Diagnosing ischemia reperfusion injury: analysis of severity markers in a pig model of kidney transplantation
Presenter: raphael Thuillier, France
HMGB-1 Mediates Injury In Renal Transplantation
Presenter: Dietmar Abendroth, Germany
MiRNA and mRNA regulation of delayed graft function in zero-hour deceased organ donor kidney biopsies
Presenter: Julia Wilflingseder, Austria
Rho-Kinase inhibition mediated by hydroxyfasudil reduces alterations in gene expression profile associated with renal ischemia-reperfusion injury in a rat model of acute renal failure
Presenter: Dominik Kentrup, Germany
High-dose antithrombin can not improve kidney function despite improved graft perfusion in human kidney transplantation – Final results of a prospective, controlled trial
Presenter: Johannes Hoffmann, Germany
Hypoxia induced tubular cell (TEC) release of HMGB1 propagates renal injury by effects on TEC viability and NK cell activation
Presenter: Arthur Lau, Canada
Multivariate Analysis of Causative Factors of Non-Function Kidney in 1856 Kidney Transplants from Non-heart-beating Deceased Donors.
Presenter: Satoshi Teraoka, Japan

Clinical Islet Transplantation
16 August 2010  /  15:30 - 16:59
Measuring of HMGB1 is a new useful potency assay to predict outcome of islet transplantation in mice.
Presenter: Takeshi Itoh, United States
Effect of ASKP1240 (4D11), a Fully Human Anti-CD40 Monoclonal Antibody, on a Single Donor-derived Allogeneic Islet Transplantation in Cynomolgus Monkeys
Presenter: Masaaki Watanabe, Japan
Double blockage of IL-1beta and TNF-alpha facilitated single donor islet transplantation
Presenter: Shinichi Matsumoto, United States
Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans
Presenter: Frantisek Saudek, Czech Republic
Influence of donor age on islet isolation and transplantation outcome
Presenter: Nadja Niclauss, Switzerland
A comparison of islet transplantation with medical therapy on the progression of diabetic complications
Presenter: David Thompson, Canada
Viable Islet Dose Based on Oxygen Consumption Rate Predicts Clinical Islet Autotransplant Outcome
Presenter: Klearchos Papas,
Alemtuzumab induction and Tac/MMF maintenance substantially improves long term insulin independence rates after clinical islet transplantation, and strongly suppresses both auto and alloreactivity
Presenter: A.M. James Shapiro, Canada

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice